Latest filing published 05 Jun 2026 for Xenon Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
Dawn Svoronos: trading record in brief
Dawn Svoronos is a declared insider of Xenon Pharmaceuticals Inc., with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 27 September 2016 to 3 June 2026.
Market trades split into 1 purchase (€94k) and 1 sale (€659k). Taken together, the sales exceed the purchases by €565k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 4 option exercises.
The record was last updated on 5 June 2026 with a share grant in Xenon Pharmaceuticals Inc. The last insider purchase was made public on 15 August 2017, 3,374 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dawn Svoronos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,593 sharesRestricted Share UnitsTSXSEDI:4730217
- 10,507 sharesOptionsTSXSEDI:4730214
- 1,416 sharesRestricted Share UnitsTSXSEDI:4730204
- 1,229 sharesCommon SharesTSXSEDI:4730169
- 1,229 sharesRestricted Share UnitsTSXSEDI:4730160
- 25,000 shares@ CA$38.7087.5% of flowCommon SharesTSXSEDI:4173398
- Common SharesTSXSEDI:3047036
- 50,000 shares@ CA$2.8154100.0% of flowCommon SharesTSXSEDI:3047040Canonical exit: 12 Nov 2017 (T+90)
8 of 8 declarations
